158 related articles for article (PubMed ID: 34190643)
1. Roles of vascular endothelial and smooth muscle cells in the vasculoprotective effect of insulin in a mouse model of restenosis.
Mori Y; Gonzalez Medina M; Liu Z; Guo J; Dingwell LS; Chiang S; Kahn CR; Husain M; Giacca A
Diab Vasc Dis Res; 2021; 18(3):14791641211027324. PubMed ID: 34190643
[TBL] [Abstract][Full Text] [Related]
2. Deletion of Krüppel-like factor 4 in endothelial and hematopoietic cells enhances neointimal formation following vascular injury.
Yoshida T; Yamashita M; Horimai C; Hayashi M
J Am Heart Assoc; 2014 Jan; 3(1):e000622. PubMed ID: 24470523
[TBL] [Abstract][Full Text] [Related]
3. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
[TBL] [Abstract][Full Text] [Related]
4. Salt-Inducible Kinase 3 Promotes Vascular Smooth Muscle Cell Proliferation and Arterial Restenosis by Regulating AKT and PKA-CREB Signaling.
Cai Y; Wang XL; Lu J; Lin X; Dong J; Guzman RJ
Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2431-2451. PubMed ID: 34196217
[TBL] [Abstract][Full Text] [Related]
5. Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injury.
Daniel JM; Reich F; Dutzmann J; Weisheit S; Teske R; Gündüz D; Bauersachs J; Preissner KT; Sedding DG
Thromb Haemost; 2015 Aug; 114(3):603-13. PubMed ID: 26063414
[TBL] [Abstract][Full Text] [Related]
6. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.
Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796
[TBL] [Abstract][Full Text] [Related]
7. Vascular smooth muscle cell-derived transforming growth factor-β promotes maturation of activated, neointima lesion-like macrophages.
Ostriker A; Horita HN; Poczobutt J; Weiser-Evans MC; Nemenoff RA
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):877-86. PubMed ID: 24526697
[TBL] [Abstract][Full Text] [Related]
8. CTP synthase 1, a smooth muscle-sensitive therapeutic target for effective vascular repair.
Tang R; Cui XB; Wang JN; Chen SY
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2336-44. PubMed ID: 24008161
[TBL] [Abstract][Full Text] [Related]
9. The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependent.
Guo J; Breen DM; Pereira TJ; Dalvi PS; Zhang H; Mori Y; Ghanim H; Tumiati L; Fantus IG; Bendeck MP; Dandona P; Rao V; Dolinsky VW; Heximer SP; Giacca A
Atherosclerosis; 2015 Jul; 241(1):111-20. PubMed ID: 25974101
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury.
Riascos-Bernal DF; Chinnasamy P; Gross JN; Almonte V; Egaña-Gorroño L; Parikh D; Jayakumar S; Guo L; Sibinga NES
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):879-888. PubMed ID: 28302627
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 5-Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β-Arrestin2-Mammalian Target of Rapamycin/p70S6K Pathway.
Liu Y; Wang Z; Li J; Ban Y; Mao G; Zhang M; Wang M; Liu Y; Zhao B; Shen Q; Xu Q; Wang N
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29382665
[TBL] [Abstract][Full Text] [Related]
12. The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells.
Smirnova NF; Fontaine C; Buscato M; Lupieri A; Vinel A; Valera MC; Guillaume M; Malet N; Foidart JM; Raymond-Letron I; Lenfant F; Gourdy P; Katzenellenbogen BS; Katzenellenbogen JA; Laffargue M; Arnal JF
Circ Res; 2015 Oct; 117(9):770-8. PubMed ID: 26316608
[TBL] [Abstract][Full Text] [Related]
13. BET bromodomain-containing epigenetic reader proteins regulate vascular smooth muscle cell proliferation and neointima formation.
Dutzmann J; Haertlé M; Daniel JM; Kloss F; Musmann RJ; Kalies K; Knöpp K; Pilowski C; Sirisko M; Sieweke JT; Bauersachs J; Sedding DG; Gegel S
Cardiovasc Res; 2021 Feb; 117(3):850-862. PubMed ID: 32353113
[TBL] [Abstract][Full Text] [Related]
14. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
[TBL] [Abstract][Full Text] [Related]
15. NFATc1-E2F1-LMCD1-Mediated IL-33 Expression by Thrombin Is Required for Injury-Induced Neointima Formation.
Govatati S; Pichavaram P; Janjanam J; Zhang B; Singh NK; Mani AM; Traylor JG; Orr AW; Rao GN
Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1212-1226. PubMed ID: 31043075
[TBL] [Abstract][Full Text] [Related]
16. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Ashino T; Yamamoto M; Yoshida T; Numazawa S
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
[TBL] [Abstract][Full Text] [Related]
17. C1q/TNF-related protein 1 prevents neointimal formation after arterial injury.
Kanemura N; Shibata R; Ohashi K; Ogawa H; Hiramatsu-Ito M; Enomoto T; Yuasa D; Ito M; Hayakawa S; Otaka N; Murohara T; Ouchi N
Atherosclerosis; 2017 Feb; 257():138-145. PubMed ID: 28131048
[TBL] [Abstract][Full Text] [Related]
18. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.
Mughal RS; Scragg JL; Lister P; Warburton P; Riches K; O'Regan DJ; Ball SG; Turner NA; Porter KE
Diabetologia; 2010 Aug; 53(8):1761-71. PubMed ID: 20461358
[TBL] [Abstract][Full Text] [Related]
19. Inducible Knockdown of Endothelial Protein Tyrosine Phosphatase-1B Promotes Neointima Formation in Obese Mice by Enhancing Endothelial Senescence.
Jäger M; Hubert A; Gogiraju R; Bochenek ML; Münzel T; Schäfer K
Antioxid Redox Signal; 2019 Mar; 30(7):927-944. PubMed ID: 29390191
[TBL] [Abstract][Full Text] [Related]
20. miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation.
Yang F; Chen Q; He S; Yang M; Maguire EM; An W; Afzal TA; Luong LA; Zhang L; Xiao Q
Circulation; 2018 Apr; 137(17):1824-1841. PubMed ID: 29246895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
